Autor(es): Rodrigues, Ana Rita O. ; Almeida, B. G. ; Rodrigues, Juliana M. ; Queiroz, Maria João R. P. ; Calhelha, Ricardo C. ; Ferreira, Isabel C. F. R. ; Pires, A. ; Pereira, A. M. ; Araújo, João P. ; Coutinho, Paulo J. G. ; Castanheira, Elisabete M. S.
Data: 2017
Identificador Persistente: https://hdl.handle.net/1822/46111
Origem: RepositóriUM - Universidade do Minho
Assunto(s): Magnetic nanoparticles; Drug delivery; Magnetoliposomes; New antitumor drugs
Magnetoliposomes containing superparamagnetic manganese ferrite nanoparticles were tested as nanocarriers for two new promising antitumor drugs, a N-(3-methoxyphenyl)thieno[3,2-b]pyridin-7-amine (1) and a N-(2-methoxy-phenyl)thieno[3,2-b]pyridin-7-amine (2). The fluorescence emission of both compounds was studied in different polar and non-polar media, evidencing a strong intramolecular charge transfer character of the excited state of both compounds. These in vitro potent antitumor thienopyridine derivatives were successfully incorporated in both aqueous and solid magnetoliposomes, with encapsulation efficiencies higher than 75%. The magnetic properties of magnetoliposomes containing manganese ferrite nanoparticles were measured for the first time, proving a superparamagnetic behaviour. Growth inhibition assays on several human tumor cell lines showed very low GI50 values for drug-loaded aqueous magnetoliposomes, comparing in most cell lines with the ones previously obtained using the neat compounds. These results are important for future drug delivery applications using magnetoliposomes in oncology, through a dual therapeutic approach (simultaneous chemotherapy and magnetic hyperthermia).
